APLT - Applied Therapeutics, Inc.
0.42
0.013 3.119%
Share volume: 1,224,839
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.41
0.01
0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2024 | 08-10-2023 | 11-09-2023 | 11-07-2024 | 05-09-2024 | 08-07-2024 | 11-07-2024 | |
| Total revenue | 10.660 M | 0.000 | 0.000 | -667.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 10.660 M | 0.000 | 0.000 | -667.000 K | 0.000 | 0.000 | 0.000 | |
| -100.00% | nan% | inf% | 100.00% | nan% | nan% | |||
| Operating expenses | 21.518 M | 17.176 M | 15.495 M | 20.339 M | 21.283 M | 20.584 M | 29.865 M | |
| Selling general and admin | 5.583 M | 5.293 M | 4.710 M | 5.037 M | 9.066 M | 10.580 M | 15.037 M | |
| Research and development | 15.935 M | 11.883 M | 10.785 M | 15.302 M | 12.217 M | 10.004 M | 14.828 M | |
| Total expenses | 21.518 M | 17.176 M | 15.495 M | 20.339 M | 21.283 M | 20.584 M | 29.865 M | |
| -20.18% | -9.79% | 31.26% | 4.64% | -3.28% | 45.09% | |||
| Operating income | -10.858 M | -17.176 M | -15.495 M | -21.006 M | -21.093 M | -20.440 M | -29.743 M | |
| Ebit | -10.358 M | -29.985 M | -42.762 M | -38.030 M | -84.524 M | 2.270 M | -69.948 M | |
| Pretax income | -10.137 M | -29.577 M | -42.370 M | -37.679 M | -83.938 M | 2.898 M | -68.591 M | |
| 191.77% | 43.25% | -11.07% | 122.77% | -103.45% | -2,466.84% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -10.137 M | -29.577 M | -42.370 M | -37.679 M | -83.938 M | 2.898 M | -68.591 M | |
| -191.77% | -43.25% | 11.07% | -122.77% | 103.45% | -2,466.84% |
